Though Affy's MicroRNA Genotyping Chips Don't Inspire Rival Offerings, Firms Say Market is Still Dynamic | GenomeWeb

Affymetrix's latest offering to researchers studying microRNA continues to stand alone in the marketplace.

A month after the firm launched catalog and custom genotyping arrays for the genome-wide evaluation of microRNA target sites, representatives for Agilent Technologies and Exiqon, two firms that compete against Affy in the miRNA array market, said they have no intention of launching a similar product. And while an Illumina representative said the firm plans to introduce arrays that include some similar content, a direct competitive offering is not planned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."